Loading...
Profiling trial burden and patients’ attitudes to improve clinical research in epidermolysis bullosa
BACKGROUND: Epidermolysis bullosa (EB) comprises inherited mechanobullous dermatoses with considerable morbidity and mortality. While current treatments are symptomatic, a growing number of innovative therapeutic compounds are evaluated in clinical trials. Clinical research in rare diseases like EB,...
Saved in:
| Published in: | Orphanet J Rare Dis |
|---|---|
| Main Authors: | , , , , , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
BioMed Central
2020
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7350741/ https://ncbi.nlm.nih.gov/pubmed/32650809 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13023-020-01443-3 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|